Transrectal Vacuum Assisted Drainage: A New Method of Treating Anastomotic Leakage After Rectal Resection

Sponsor
Hvidovre University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00773981
Collaborator
Braun Aesculap (Other)
60
1
2
36
1.7

Study Details

Study Description

Brief Summary

Anastomotic leakage is a major and potentially mortal complication with an incidence of 10-13% after resection of the rectum. For patients showing no clinical signs of peritonitis, the traditional method has been a conservative treatment with transrectal rinsing. This treatment is often associated with a very protracted postoperative course with healing times of up to a year or more for the anastomotic leakage.

Treatment with vacuum drainage (VD) is a new method primarily developed for wound therapy.

The objective of this study is to investigate the effects of transrectal vacuum treatment on the healing of anastomotic leakage after rectum resection in a prospective, randomized, controlled multicentre trial in 60 patients found to develop clinically significant anastomotic leakages after elective rectal resection.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Transrectal vacuum assisted drainage
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Transrectal Vacuum Assisted Drainage: A NEW METHOD OF TREATING ANASTOMOTIC LEAKAGE AFTER RECTAL RESECTION. A Prospective Randomized Multicenter Study in Cooperation With "The Danish Colorectal Cancer Group"
Study Start Date :
Oct 1, 2008
Anticipated Primary Completion Date :
Oct 1, 2011
Anticipated Study Completion Date :
Oct 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

Endoluminal vacuum therapy.

Procedure: Transrectal vacuum assisted drainage
Treatment with vacuum drainage (VD) is a new method primarily developed for wound therapy. The principle of the method is application of negative pressure on the wound surface with the help of a sponge that is connected to a pump. Sponge dressings should be changed 3 times pr week as long as vacuum therapy is used. If there has been no development of granulation tissue or no shrinking of the cavity in 3 weeks Vacuum therapy can be stopped. Maximum vacuum therapy is 8 weeks.

No Intervention: 2

Patients not receiving vacuum therapy should be treated with a catheter with daily rinsing for a minimum of 7 days.

Outcome Measures

Primary Outcome Measures

  1. Healing time of the anastomotic leakage [1 year]

Secondary Outcome Measures

  1. Salvage surgery (abdominal reoperation with debridement of anastomosis) [1 month]

  2. Duration of fever and antibiotic treatment [2 months]

  3. Duration of hospital stay [2 monts]

  4. Number of visits in the outpatient clinic / number of sponge changes [8 weeks]

  5. Functional result, defined as +/- closure of temporary ileostomy [2 years]

  6. Functional result evaluated by examination of the anal physiology in a smaller patient population (supplementary trial protocol) [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with clinically significant* anastomotic leakage after intended curative rectal resection (LAR) for rectal cancer with primary anastomosis.

  • Patients whose operation did not include ileostomy must have surgery to create a stoma within two days after beginning of the vacuum therapy and before randomization. Anastomotic leakage must have been diagnosed within 21 days of the primary operation.

  • Patients with and without preoperative radiation therapy may participate.

  • Groups will be formed accordingly, because patients who had preoperative radiation therapy heal more slowly.

  • Patients with anastomotic leakage (diagnosed by endoscopic or radiology techniques) and clinical signs and symptoms indicating a health impairment (fever, pain, elevated creatinine levels).

  • Anastomotic leakage after rectal cancer surgery

Exclusion Criteria:
  • Informed consent

  • Age < 18 years

  • Acute surgery

  • Leakage diagnosed more than 21 days after the primary operation

  • Patient does not consent to temporary ileostomy

  • Anastomosis technically inaccessible for vacuum-assisted drainage

  • Small intestine visible in abscess cavity

  • Residual cancer tissue in the pelvic cavity

  • Suspicion of fistulation between the abscess cavity and internal genitalia, urinary tract system, or small intestines.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hvidovre University Hospital Hvidovre Denmark 2650

Sponsors and Collaborators

  • Hvidovre University Hospital
  • Braun Aesculap

Investigators

  • Principal Investigator: Carl F Nagell, MD, Hamlet Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00773981
Other Study ID Numbers:
  • H-B-2007-061
First Posted:
Oct 16, 2008
Last Update Posted:
Nov 4, 2008
Last Verified:
Oct 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 4, 2008